Lymphadenopathy historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lymphadenopathy}} | {{Lymphadenopathy}} | ||
{{CMG}}{{AE}}{{ADS}} | {{CMG}}, {{AE}}{{ADS}} | ||
==Overview== | ==Overview== | ||
There is limited information about the historical perspective of lymphadenopathy. | There is limited information about the historical perspective of lymphadenopathy. | ||
Line 12: | Line 12: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Inflammations]] | [[Category:Inflammations]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] |
Latest revision as of 15:07, 7 February 2019
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy historical perspective On the Web |
American Roentgen Ray Society Images of Lymphadenopathy historical perspective |
Risk calculators and risk factors for Lymphadenopathy historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
There is limited information about the historical perspective of lymphadenopathy.
Historical Perspective
Discovery
- There is limited information about the historical perspective of lymphadenopathy.